Diabetic enteropathy
Diabetic enteropathy is infrequent, but severe and more resistant to treatment manifestation of diabetes mellitus. The pathogenesis of diabetic enteropathy, including neuropathy, clinical manifestations, diagnostic methods and treatment approaches are discussed. In diabetic polyneuropathy, causal treatment (targeted normoglycemia) is basis of treatment strategy; various preparations of alpha-lipoic acid and B vitamins, including soluble forms of thiamine (benfotiamine, Milgamma) are widely used due to high bioavailability and neurotropic activity.